Combination chemotherapy with CCNU (NSC 79037) and 5 [3,3 bis (2 chloroethyl) 1 thiazeno] imidazole 4 carboxamide (NSC 82196)

H. Y. Chang, E. J. Freireich, A. Khaliq, Lawrence Einhorn, J. A. Gottlieb

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The authors designed a study to determine the efficacy and toxicity of combination treatment with CCNU and NSC 82196 (5-[3,3 Bis(2 chloroethyl) 1 triazeno]imidazole 4 carboxamide) in patients with advanced (predominantly refractory) solid tumors, especially adeno carcinomas. Twenty three patients, 12 men and 11 women ranging in age from 17 to 76 years with a median age of 52, with a variety of disseminated solid tumors were treated.

Original languageEnglish (US)
Title of host publicationCANCER CHEMOTHER.REP.
Pages769-771
Number of pages3
Volume59
Edition4
StatePublished - 1975
Externally publishedYes

Fingerprint

imidazole mustard
Lomustine
Combination Drug Therapy
Neoplasms
Carcinoma
imidazole-4-carboxamide
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chang, H. Y., Freireich, E. J., Khaliq, A., Einhorn, L., & Gottlieb, J. A. (1975). Combination chemotherapy with CCNU (NSC 79037) and 5 [3,3 bis (2 chloroethyl) 1 thiazeno] imidazole 4 carboxamide (NSC 82196). In CANCER CHEMOTHER.REP. (4 ed., Vol. 59, pp. 769-771)

Combination chemotherapy with CCNU (NSC 79037) and 5 [3,3 bis (2 chloroethyl) 1 thiazeno] imidazole 4 carboxamide (NSC 82196). / Chang, H. Y.; Freireich, E. J.; Khaliq, A.; Einhorn, Lawrence; Gottlieb, J. A.

CANCER CHEMOTHER.REP.. Vol. 59 4. ed. 1975. p. 769-771.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chang, HY, Freireich, EJ, Khaliq, A, Einhorn, L & Gottlieb, JA 1975, Combination chemotherapy with CCNU (NSC 79037) and 5 [3,3 bis (2 chloroethyl) 1 thiazeno] imidazole 4 carboxamide (NSC 82196). in CANCER CHEMOTHER.REP.. 4 edn, vol. 59, pp. 769-771.
Chang HY, Freireich EJ, Khaliq A, Einhorn L, Gottlieb JA. Combination chemotherapy with CCNU (NSC 79037) and 5 [3,3 bis (2 chloroethyl) 1 thiazeno] imidazole 4 carboxamide (NSC 82196). In CANCER CHEMOTHER.REP.. 4 ed. Vol. 59. 1975. p. 769-771
Chang, H. Y. ; Freireich, E. J. ; Khaliq, A. ; Einhorn, Lawrence ; Gottlieb, J. A. / Combination chemotherapy with CCNU (NSC 79037) and 5 [3,3 bis (2 chloroethyl) 1 thiazeno] imidazole 4 carboxamide (NSC 82196). CANCER CHEMOTHER.REP.. Vol. 59 4. ed. 1975. pp. 769-771
@inbook{e24f45d4201742bb9b2af8f546f72bc0,
title = "Combination chemotherapy with CCNU (NSC 79037) and 5 [3,3 bis (2 chloroethyl) 1 thiazeno] imidazole 4 carboxamide (NSC 82196)",
abstract = "The authors designed a study to determine the efficacy and toxicity of combination treatment with CCNU and NSC 82196 (5-[3,3 Bis(2 chloroethyl) 1 triazeno]imidazole 4 carboxamide) in patients with advanced (predominantly refractory) solid tumors, especially adeno carcinomas. Twenty three patients, 12 men and 11 women ranging in age from 17 to 76 years with a median age of 52, with a variety of disseminated solid tumors were treated.",
author = "Chang, {H. Y.} and Freireich, {E. J.} and A. Khaliq and Lawrence Einhorn and Gottlieb, {J. A.}",
year = "1975",
language = "English (US)",
volume = "59",
pages = "769--771",
booktitle = "CANCER CHEMOTHER.REP.",
edition = "4",

}

TY - CHAP

T1 - Combination chemotherapy with CCNU (NSC 79037) and 5 [3,3 bis (2 chloroethyl) 1 thiazeno] imidazole 4 carboxamide (NSC 82196)

AU - Chang, H. Y.

AU - Freireich, E. J.

AU - Khaliq, A.

AU - Einhorn, Lawrence

AU - Gottlieb, J. A.

PY - 1975

Y1 - 1975

N2 - The authors designed a study to determine the efficacy and toxicity of combination treatment with CCNU and NSC 82196 (5-[3,3 Bis(2 chloroethyl) 1 triazeno]imidazole 4 carboxamide) in patients with advanced (predominantly refractory) solid tumors, especially adeno carcinomas. Twenty three patients, 12 men and 11 women ranging in age from 17 to 76 years with a median age of 52, with a variety of disseminated solid tumors were treated.

AB - The authors designed a study to determine the efficacy and toxicity of combination treatment with CCNU and NSC 82196 (5-[3,3 Bis(2 chloroethyl) 1 triazeno]imidazole 4 carboxamide) in patients with advanced (predominantly refractory) solid tumors, especially adeno carcinomas. Twenty three patients, 12 men and 11 women ranging in age from 17 to 76 years with a median age of 52, with a variety of disseminated solid tumors were treated.

UR - http://www.scopus.com/inward/record.url?scp=0016824129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016824129&partnerID=8YFLogxK

M3 - Chapter

VL - 59

SP - 769

EP - 771

BT - CANCER CHEMOTHER.REP.

ER -